- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03118726
Evaluation of Immediate Postpartum LARC Implementation Programs
August 26, 2019 updated by: Lisa Hofler, University of New Mexico
This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs.
All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in the NPMC program evaluation.
The study will evaluate the components of this implementation program at several New Mexico hospitals using a stepped wedge design,with components being introduced to each hospital one at a time
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
21
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- University of New Mexico
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs.
All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in the NPMC program evaluation.
The study will evaluate the components of this implementation program at several New Mexico hospitals using a stepped wedge design, with components being introduced to each hospital one at a time.
Description
Inclusion Criteria:
- Hospital staff: Important individuals at New Mexico hospitals planning to implement immediate postpartum LARC programs, with an emphasis on diversity of administrative perspectives.
- If more than 4 potential participants are identified at one institution, additional participants may be included if their participation in the study is likely to contribute additional information (e.g. job title or background is different from other study participants)
Exclusion Criteria:
- Inability to speak and read English proficiently
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
|---|
|
NM Perinatal Collaborative
Hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline immediate postpartum LARC Implementation
Time Frame: April 2017-December 2018
|
To determine baseline immediate postpartum LARC implementation in various rural New Mexico hospitals.
|
April 2017-December 2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lisa Hofler, MD, MBA, MPH, University of New Mexico
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 13, 2017
Primary Completion (Actual)
May 31, 2018
Study Completion (Actual)
May 31, 2019
Study Registration Dates
First Submitted
April 12, 2017
First Submitted That Met QC Criteria
April 17, 2017
First Posted (Actual)
April 18, 2017
Study Record Updates
Last Update Posted (Actual)
August 28, 2019
Last Update Submitted That Met QC Criteria
August 26, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17-051
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Partum Contraception
-
Karolinska InstitutetThe Swedish Research Council; ForteRecruitingContraception | Post Partum | ImmigrantSweden
-
Cairo UniversityRecruiting
-
Chulalongkorn UniversityCompletedBreastfeeding | Post PartumThailand
-
University of AlcalaCompleted
-
University of EdinburghMaternal, Neonatal and Child Health Research NetworkCompleted
-
The University of Texas Health Science Center,...American Heart AssociationRecruitingFood Insecurity in Post Partum WomenUnited States
-
Emory UniversityWoodruff Health Sciences Center FoundationCompletedPost Abortion ContraceptionUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
-
Foundation University IslamabadRecruitingPost Partum | Sacro Iliac Joint Pain | Strength TrainingPakistan
-
Duke UniversityNot yet recruitingPost Partum | Maternal Depression | Maternal Depression and Parent Practices, PostpartumUnited States